Skip to main content
NCBI home page
Gut logoLink to Gut
. 1987 Dec;28(12):1648–1652. doi: 10.1136/gut.28.12.1648

Effect of recombinant interleukin 2 on hepatitis B e antigen positive chronic hepatitis.

M Onji 1, H Kondoh 1, N Horiike 1, S Yamaguchi 1, Y Ogawa 1, I Kumon 1, Y Ohta 1
PMCID: PMC1433944  PMID: 3501387

Abstract

Eleven patients with hepatitis B (HB) virus related chronic hepatitis were treated with recombinant interleukin 2 (rIL 2). Two hundred and fifty to 1000 units were given intravenously once daily for seven to 28 days. In five patients serum glutamic pyruvic transaminase activity rose transiently. Six patients showed a decrease in HBV DNA polymerase. One patient lost HBs, e antigens (Ags) and gained anti-HBs, e antibodies, while one lost HBs Ag and another HBe Ag. 2'-5' oligoadenylate synthetase activity in mononuclear cells in the peripheral blood did not change during treatment. The number of CD4 positive (helper/inducer) cells and natural killer cell activity increased after therapy (p less than 0.05, p less than 0.01). These results suggest that rIL 2 acts as an immunomodulatory agent enhancing host immune activity and may be beneficial in patients with chronic HB virus infection.

Full text

PDF
1648

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  2. Gillis S., Smith K. A. Long term culture of tumour-specific cytotoxic T cells. Nature. 1977 Jul 14;268(5616):154–156. doi: 10.1038/268154a0. [DOI] [PubMed] [Google Scholar]
  3. Ikeda T., Pignatelli M., Lever A. M., Thomas H. C. Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection. Gut. 1986 Dec;27(12):1498–1501. doi: 10.1136/gut.27.12.1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kaplan P. M., Greenman R. L., Gerin J. L., Purcell R. H., Robinson W. S. DNA polymerase associated with human hepatitis B antigen. J Virol. 1973 Nov;12(5):995–1005. doi: 10.1128/jvi.12.5.995-1005.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ralph P., Jeong G., Welte K., Mertelsmann R., Rabin H., Henderson L. E., Souza L. M., Boone T. C., Robb R. J. Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2. J Immunol. 1984 Nov;133(5):2442–2445. [PubMed] [Google Scholar]
  6. Thomas H. C., Scully L. J. Antiviral therapy in hepatitis B infection. Br Med Bull. 1985 Oct;41(4):374–380. doi: 10.1093/oxfordjournals.bmb.a072079. [DOI] [PubMed] [Google Scholar]
  7. Vilcek J., Henriksen-Destefano D., Siegel D., Klion A., Robb R. J., Le J. Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2. J Immunol. 1985 Sep;135(3):1851–1856. [PubMed] [Google Scholar]
  8. Zarling J. M., McKeough M., Bach F. H. A sensitive micromethod for generating and assaying allogeneically induced cytotoxic human lymphocytes. Transplantation. 1976 Jun;21(6):468–476. doi: 10.1097/00007890-197606000-00005. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES